Clinical Trial Update: A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency [Phase 2]

View source ↗

Summary

Phase 2 single-dose PK-PD and safety study of PHA-794428 in children with growth hormone deficiency; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• PHA-794428

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Deficiency | Phase 2 | Status: TERMINATED